Evidence map›Paper›PMID 20052766›Full record

ArticleHuman mutation2010

Complete ascertainment of intragenic copy number mutations (CNMs) in the CFTR gene and its implications for CNM formation at other autosomal loci.

Sylvia Quemener, Jian-Min Chen, Nadia Chuzhanova, Caroline Bénech, Teresa Casals, Milan Macek, Thierry Bienvenu, Trudi McDevitt, Philip M Farrell, Ourida Loumi and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Human mutation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Decoding NF1 Intragenic Copy-Number Variations.American journal of human genetics · 2015
    Article
  7. Article
  8. Article
  9. Discovery of variants unmasked by hemizygous deletions.European journal of human genetics : EJHG · 2012
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 8 countries.

Sylvia QuemenerINSERM U613, and Université de Bretagne Occidentale, 46 rue Félix Le Dantec, Brest, France.
Jian-Min Chen
Nadia Chuzhanova
Caroline Bénech
Teresa Casals
Milan Macek
Thierry Bienvenu
Trudi McDevitt
Philip M Farrell
Ourida Loumi
Taieb Messaoud
Harry Cuppens
Garry R Cutting
Peter D Stenson
Karine Giteau
Marie-Pierre Audrézet
David N Cooper
Claude Férec
Inserm · FRCardiff University · GBCentre Hospitalier Régional Universitaire de Brest · FRCharles University · CZHôpital Cochin · FRInstitut d'Investigació Biomédica de Bellvitge · ESJohns Hopkins University · USKU Leuven · BEUniversity College Dublin · IEUniversity of Lancashire · GBUniversity of Sciences and Technology Houari Boumediene · DZUniversity of Wisconsin–Madison · US

Funding

PULMONARY BENEFITS OF CYSTIC FIBROSIS NEONATAL SCREENINGR01DK034108 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI FARRELL, PHILIP M · 1986 to 2011
$6.9M
Molecular Genetics of Cystic FibrosisR37DK044003 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI CUTTING, GARRY R · 2003 to 2012
$3.9M
NIDDK NIH HHS R01 DK034108NIDDK NIH HHS R37 DK044003
6 · The paper itself

Abstract

Over the last 20 years since the discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, more than 1,600 different putatively pathological CFTR mutations have been identified. Until now, however, copy number mutations (CNMs) involving the CFTR gene have not been methodically analyzed, resulting almost certainly in the underascertainment of CFTR gene duplications compared with deletions. Here, high-resolution array comparative genomic hybridization (averaging one interrogating probe every 95 bp) was used to analyze the entire length of the CFTR gene (189 kb) in 233 cystic fibrosis chromosomes lacking conventional mutations. We succeeded in identifying five duplication CNMs that would otherwise have been refractory to analysis. Based upon findings from this and other studies, we propose that deletion and duplication CNMs in the human autosomal genome are likely to be generated in the proportion of approximately 2-3:1. We further postulate that intragenic gene duplication CNMs in other disease loci may have been routinely underascertained. Finally, our analysis of +/-20 bp flanking each of the 40 CFTR breakpoints characterized at the DNA sequence level provide support for the emerging concept that non-B DNA conformations in combination with specific sequence motifs predispose to both recurring and nonrecurring genomic rearrangements.

Indexed as

Base SequenceComparative Genomic HybridizationCystic Fibrosis Transmembrane Conductance RegulatorDNA Copy Number VariationsGenetic LociGenetic Predisposition to DiseaseHumansMutationCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID20052766
PMCPMC2855493
OpenAlexW2049637347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.